SCHEMBL4728302

SCHEMBL4728302

CC(C)(C)c1cc(C(=O)O)cc(S(=O)(=O)Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.46
RXRB P28702 4/20 0.46
RXRG P48443 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
TDP1 Q9NUW8 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
BLM P54132 1/20 0.42
CASP7 P55210 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SRD5A2 P31213 1/20 0.42
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 1/20 0.41
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11668400 0.82 LCK (0.58) LCKFYNTDP1SMN1; SMN2TP53
SCHEMBL701628 0.82 GABRA1 (0.42) RXRARXRBRXRGTDP1HSD17B10
SCHEMBL11346857 0.82 ALDH1A1 (0.40) TDP1SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL134325 0.82 LCK (0.64) LCKFYNTDP1SMN1; SMN2TP53
SCHEMBL5363665 0.82 CES2 (0.47) RXRARXRBRXRGLCKFYN
Hydrochloric Acid SCHEMBL6130934 0.81 LCK (0.61) LCKFYNTDP1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL10778510 0.81 LCK (0.61) LCKFYNTDP1SMN1; SMN2TP53
SCHEMBL501957 0.80 RXRB (0.64) RXRARXRBRXRGLCKFYN
SCHEMBL166878 0.80 RXRB (0.59) RXRARXRBRXRGLCKFYN
SCHEMBL4782469 0.79 ALDH1A1 (0.51) RXRARXRBRXRGLCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021388-A1 HETEROARYL DERIVATIVES AS CYTOKINE INHIBITORS KEMIA, INC. (US) 2008-02-21 WO disclosed